Over the past 12 months, 6 insiders at BECTON DICKINSON & CO filed 23 open-market SEC Form 4 transactions on BDX: 1 purchase worth $1.0M and 22 sales worth $1.9M. Insiders have been net sellers over this period. The most recent filing was on Jul 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 27, 26 | Michael FeldEVP, Chief Revenue Officer | SELL | 75 | $157.13 | $12K |
| Jun 26, 26 | Michael FeldEVP, Chief Revenue Officer | SELL | 75 | $152.80 | $11K |
| Jun 24, 26 | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | SELL | 1.1K | $145.66 | $160K |
| Jun 10, 26 | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | SELL | 1.1K | $151.48 | $167K |
| Jun 1, 26 | Thomas E Polen JrChairman, CEO and President | SELL | 2.8K | $146.35 | $405K |
| May 26, 26 | Michael FeldEVP, Chief Revenue Officer | SELL | 75 | $147.35 | $11K |
| Apr 27, 26 | Michael FeldEVP, Chief Revenue Officer | SELL | 74 | $151.94 | $11K |
| Mar 26, 26 | Michael FeldEVP, Chief Revenue Officer | SELL | 75 | $156.83 | $12K |
| Feb 26, 26 | Michael FeldEVP, Chief Revenue Officer | SELL | 75 | $181.84 | $14K |
| Feb 18, 26 | Bertram L ScottDirector | SELL | 953 | $182.61 | $174K |
| Jan 26, 26 | Michael FeldEVP, CRO & Pres. Life Sciences | SELL | 75 | $202.73 | $15K |
| Jan 15, 26 | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | SELL | 1.0K | $209.00 | $209K |
| Dec 26, 25 | Michael FeldEVP, CRO & Pres. Life Sciences | SELL | 74 | $196.08 | $15K |
| Dec 17, 25 | Michael David GarrisonEVP & Pres Med.Essntl&BioPharm | SELL | 629 | $196.03 | $123K |
| Dec 1, 25 | Michael FeldEVP, CRO & Pres. Life Sciences | SELL | 75 | $193.36 | $15K |
| Nov 7, 25 | Bertram L ScottDirector | SELL | 217 | $176.58 | $38K |
| Oct 27, 25 | Michael FeldEVP & President, Life Sciences | SELL | 57 | $186.01 | $11K |
| Sep 26, 25 | Michael FeldEVP & President, Life Sciences | SELL | 58 | $181.03 | $11K |
| Sep 10, 25 | Claire FraserDirector | SELL | 917 | $187.50 | $172K |
| Aug 22, 25 | Michael FeldEVP & President, Life Sciences | SELL | 57 | $197.99 | $11K |
| Aug 11, 25 | Gregory HayesDirector | BUY | 5.3K | $191.57 | $1.0M |
| Aug 8, 25 | Claire FraserDirector | SELL | 863 | $192.30 | $166K |
| Jul 18, 25 | Michael David GarrisonEVP & President, Medical | SELL | 1.2K | $181.50 | $213K |
| Jun 2, 25 | David ShanEVP and Chief ISC Officer | SELL | 1.2K | $171.19 | $200K |
| Apr 9, 25 | Michael David GarrisonEVP & President, Medical | SELL | 479 | $197.28 | $94K |
| Mar 18, 25 | Richard ByrdEVP & President Interventional | SELL | 459 | $230.00 | $106K |
| Mar 12, 25 | Richard ByrdEVP & President Interventional | SELL | 1.9K | $224.91 | $436K |
| Feb 12, 25 | Bertram L ScottDirector | SELL | 700 | $227.99 | $160K |
| Feb 10, 25 | Jeffrey William HendersonDirector | BUY | 1.5K | $233.62 | $350K |
| Jan 21, 25 | Shana Carol NealEVP and Chief People Officer | SELL | 787 | $240.00 | $189K |
| Jan 21, 25 | David ShanEVP and Chief ISC Officer | SELL | 500 | $240.00 | $120K |
| Jan 17, 25 | Michael David GarrisonEVP & President, Medical | SELL | 597 | $236.51 | $141K |
| Jan 7, 25 | Shana Carol NealEVP and Chief People Officer | SELL | 788 | $235.00 | $185K |
| Dec 19, 24 | Michael David GarrisonEVP & President, Medical | SELL | 2.8K | $223.33 | $634K |
| Dec 9, 24 | Roland GoetteEVP and President, EMEA | SELL | 638 | $219.03 | $140K |
| Dec 6, 24 | Roland GoetteEVP and President, EMEA | SELL | 4.5K | $221.01 | $991K |
| Dec 6, 24 | Shana Carol NealEVP and Chief People Officer | SELL | 1.0K | $220.49 | $220K |
| Dec 5, 24 | David ShanEVP and Chief ISC Officer | SELL | 1.5K | $220.25 | $330K |
| Jun 10, 24 | Thomas J SpoerelSVP,Controller&Chief Acct Off | SELL | 300 | $239.31 | $72K |
| May 15, 24 | Roland GoetteEVP and President EMEA | SELL | 1.4K | $237.46 | $332K |
| May 13, 24 | Roland GoetteEVP and President EMEA | SELL | 1.7K | $237.90 | $402K |
| Apr 30, 24 | Michael David GarrisonEVP & President Medical | SELL | 1.7K | $232.81 | $399K |
| Mar 14, 24 | Thomas J SpoerelSVP,Controller&Chief Acct Off | SELL | 282 | $238.29 | $67K |
| Dec 11, 23 | Michael David GarrisonEVP & President Medical | SELL | 1.2K | $232.46 | $288K |
| Nov 28, 23 | Richard ByrdEVP & President Interventional | SELL | 2.2K | $238.47 | $514K |
| Sep 5, 23 | Richard ByrdEVP & President Interventional | SELL | 459 | $274.48 | $126K |
| Aug 28, 23 | Claire FraserDirector | SELL | 848 | $281.66 | $239K |
| Aug 11, 23 | David HickeyEVP & President, Life Sciences | SELL | 3.0K | $277.85 | $826K |
| Aug 8, 23 | Michael David GarrisonEVP & President Medical | SELL | 1.3K | $277.13 | $360K |
| Feb 3, 23 | Richard ByrdEVP & President Interventional | SELL | 1.4K | $248.60 | $353K |
Over the past 12 months, insiders at BECTON DICKINSON & CO filed 1 open-market purchase worth $1.0M and 22 sales worth $1.9M on BDX, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 27, 26.
The largest recent open-market BDX insider purchase in our data was $1.0M by Gregory Hayes, Director, filed on Aug 11, 25.
6 different insiders at BECTON DICKINSON & CO filed open-market SEC Form 4 transactions on BDX over the last 12 months.
InsiderTape plots every BDX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every BECTON DICKINSON & CO insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →